Literature DB >> 3110378

Gamma-interferon: physiology and speculation on its role in medicine.

E M Bonnem, R K Oldham.   

Abstract

Gamma-interferon appears to be a pivotal molecule in the immune system. Recombinant DNA technology has permitted the cloning and expression of the gene for gamma-interferon (gamma-IFN), leading to an exponential increase in the level of knowledge both in vitro and in vivo. Laboratory evidence suggests a clinical role for gamma-IFN in collagen vascular disease, chronic granulomatous infectious diseases, hematology, and medical oncology. Phase I trials have identified the toxicities; these toxicities are primarily clinical and include fever, fatigue, flu-like symptoms, and hypotension. Antitumor activity has been noted in the early development of the drug.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110378

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN: 0732-6580


  9 in total

1.  Effects of gamma-IFN and NGF on subpopulations in a human neuroblastoma cell line: flow cytometric and morphological analysis.

Authors:  J Ridge; D A Terle; E Dragunsky; I Levenbook
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

Review 2.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Interferon for treatment.

Authors:  A Galazka; E Scott
Journal:  BMJ       Date:  1988 Aug 20-27

4.  Myeloma-like cast nephropathy caused by human recombinant soluble CD4 (sCD4) in monkeys.

Authors:  P J Bugelski; H A Solleveld; K L Fong; A M Klinkner; T K Hart; D G Morgan
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

5.  Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.

Authors:  J Higashihara; T Saito; M E Berens; C E Welander
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 6.  Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

7.  Is alpha-methyldopa-type autoimmune hemolytic anemia mediated by interferon-gamma?

Authors:  J E Baier; D Poehlau
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

8.  Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.

Authors:  A D Roth; F J Hornicek; C G Gerstner; J M Kirkwood
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo.

Authors:  Ruchi Bansal; Jai Prakash; Marieke De Ruiter; Klaas Poelstra
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.